{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:54:45Z","timestamp":1783547685041,"version":"3.55.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Cerebral palsy (CP) is a non-progressive neurodevelopmental disorder characterized by motor impairments, often accompanied by co-morbidities such as intellectual disability, epilepsy, visual and hearing impairment and speech and language deficits. Despite the established role of hypoxic\u2013ischemic injury in some CP cases, several studies suggest that birth asphyxia is actually an uncommon cause, accounting for &amp;lt;10% of CP cases. For children with CP in the absence of traditional risk factors, a genetic basis to their condition is increasingly suspected. Several recent studies indeed confirm copy number variants and single gene mutations with large genetic heterogeneity as an etiology in children with CP. Here, we report three patients with spastic cerebral palsy and a genetically confirmed diagnosis of Aicardi-Gouti\u00e8res syndrome (AGS), with highly variable phenotypes ranging from clinically suggestive to non-specific symptomatology. Our findings suggest that AGS may be a rather common cause of CP, that frequently remains undiagnosed without additional genetic testing, as in only one case a clinical suspicion of AGS was raised. Our data show that a diagnosis of AGS must be considered in cases with spastic CP, even in the absence of characteristic brain abnormalities. Importantly, a genetic diagnosis of AGS may have significant therapeutic consequences, as targeted therapies are being developed for type 1 interferonopathies, the group of diseases to which AGS belongs. Our findings demonstrate the importance of next generation sequencing in CP patients without an identifiable cause, since targeted diagnostic testing is hampered by the often non-specific presentation.<\/jats:p>","DOI":"10.3389\/fneur.2021.617813","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T05:48:42Z","timestamp":1619070522000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Genetic Testing Contributes to Diagnosis in Cerebral Palsy: Aicardi-Gouti\u00e8res Syndrome as an Example"],"prefix":"10.3389","volume":"12","author":[{"given":"Diane","family":"Beysen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chania","family":"De Cordt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Dielman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Ogunjimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dandelooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Reyniers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije M.E.","family":"Meuwissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.berh.2017.12.002","article-title":"Genetic interferonopathies: an overview","volume":"31","author":"Eleftheriou","year":"2017","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/dmcn.14585","article-title":"Definition and diagnosis of cerebral palsy in genetic studies: a systematic review","volume":"62","author":"Pham","year":"2020","journal-title":"Dev Med Child Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pediatrneurol.2017.09.002","article-title":"Phenotypic and molecular spectrum of aicardi-goutieres syndrome: a study of 24 patients","volume":"78","author":"Al Mutairi","year":"2018","journal-title":"Pediatr Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/521373","article-title":"Clinical and molecular phenotype of aicardi-goutieres syndrome","volume":"81","author":"Rice","year":"2007","journal-title":"Am J Hum Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12519-019-00273-z","article-title":"Toward a better understanding of type I interferonopathies: a brief summary, update and beyond","volume":"16","author":"Yu","year":"2020","journal-title":"World J Pediatr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1174","DOI":"10.1016\/S2214-109X(17)30420-5","article-title":"Making sense of cerebral palsy prevalence in low-income countries","volume":"5","author":"Dan","year":"2017","journal-title":"Lancet Glob Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/dmcn.12080","article-title":"An update on the prevalence of cerebral palsy: a systematic review and meta-analysis","volume":"55","author":"Oskoui","year":"2013","journal-title":"Dev Med Child Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ajog.2008.06.094","article-title":"A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy","volume":"199","author":"Graham","year":"2008","journal-title":"Am J Obstet Gynecol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13023-014-0197-2","article-title":"Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review","volume":"9","author":"Leach","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s12017-014-8331-9","article-title":"A diagnostic approach for cerebral palsy in the genomic era","volume":"16","author":"Lee","year":"2014","journal-title":"Neuromolecular Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-12-4","article-title":"CNV-WebStore: online CNV analysis, storage and interpretation","volume":"12","author":"Vandeweyer","year":"2011","journal-title":"BMC Bioinformatics."},{"key":"B12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13073-014-0074-6","article-title":"VariantDB: a flexible annotation and filtering portal for next generation sequencing data","volume":"6","author":"Vandeweyer","year":"2014","journal-title":"Genome Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/humu.22087","article-title":"SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutieres syndrome-associated mutations","volume":"33","author":"Goncalves","year":"2012","journal-title":"Hum Mutat."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.4049\/jimmunol.1403157","article-title":"Characterization of samhd1 morphant zebrafish recapitulates features of the human type I interferonopathy Aicardi-Goutieres syndrome","volume":"194","author":"Kasher","year":"2015","journal-title":"J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"101697","DOI":"10.1016\/j.scr.2019.101697","article-title":"Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi-Goutieres syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1)","volume":"43","author":"Fuchs","year":"2020","journal-title":"Stem Cell Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/mdc3.12903","article-title":"Diagnosis of aicardi-goutieres syndrome in adults: a case series","volume":"7","author":"Videira","year":"2020","journal-title":"Mov Disord Clin Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/dmcn.13509","article-title":"Late diagnosis and atypical brain imaging of Aicardi-Goutieres syndrome: are we failing to diagnose aicardi-goutieres syndrome-2?","volume":"59","author":"Svingen","year":"2017","journal-title":"Dev Med Child Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1055\/s-0036-1592307","article-title":"Neurologic phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: aicardi-goutieres syndrome and beyond","volume":"47","author":"Livingston","year":"2016","journal-title":"Neuropediatrics."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","article-title":"Assessment of interferon-related biomarkers in aicardi-goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study","volume":"12","author":"Rice","year":"2013","journal-title":"Lancet Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e13893","DOI":"10.1097\/MD.0000000000013893","article-title":"Sine causa tetraparesis: a pilot study on its possible relationship with interferon signature analysis and Aicardi Goutieres syndrome related genes analysis","volume":"97","author":"Galli","year":"2018","journal-title":"Medicine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/1744666X.2019.1707663","article-title":"Novel and emerging treatments for aicardi-goutieres syndrome","volume":"16","author":"Tonduti","year":"2020","journal-title":"Expert Rev Clin Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/dmcn.14268","article-title":"Treatments in aicardi-goutieres syndrome","volume":"62","author":"Crow","year":"2020","journal-title":"Dev Med Child Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"7949","DOI":"10.1038\/ncomms8949","article-title":"Clinically relevant copy number variations detected in cerebral palsy","volume":"6","author":"Oskoui","year":"2015","journal-title":"Nat Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/gim.2017.83","article-title":"De novo and rare inherited copy-number variations in the hemiplegic form of cerebral palsy","volume":"20","author":"Zarrei","year":"2018","journal-title":"Genet Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/mp.2014.189","article-title":"Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy","volume":"20","author":"McMichael","year":"2015","journal-title":"Mol Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/s41436-018-0376-y","article-title":"Atypical cerebral palsy: genomics analysis enables precision medicine","volume":"21","author":"Matthews","year":"2019","journal-title":"Genet Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41525-019-0101-z","article-title":"Targeted resequencing identifies genes with recurrent variation in cerebral palsy","volume":"4","author":"van Eyk","year":"2019","journal-title":"NPJ Genom Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/0883073819840449","article-title":"Genetic or other causation should not change the clinical diagnosis of cerebral palsy","volume":"34","author":"MacLennan","year":"2019","journal-title":"J Child Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.617813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T05:48:45Z","timestamp":1619070525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.617813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":28,"alternative-id":["10.3389\/fneur.2021.617813"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.617813","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]},"article-number":"617813"}}